Additionally, it has been demonstrated that the active features of BC-associated fibroblasts cells, major components of the tumor microenvironment, could be normalized through drug targeting of DNMT1/DNMT3A and the consequent modulation in gene methylation (Al-Kharashi et al., 2021). The gene discussed is DNMT3A; the disease is neoplasm.